Nutex Health Inc. - Common Stock, $0.001 par value (NUTX)
CUSIP: 67079U306
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 6,961,308
- Total 13F shares
- 24
- Share change
- +4
- Total reported value
- $2,281
- Price per share
- $95.04
- Number of holders
- 1
- Value change
- +$171
- Number of buys
- 1
- Number of sells
- 1
Quarterly Holders Quick Answers
What is CUSIP 67079U306?
CUSIP 67079U306 identifies NUTX - Nutex Health Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 67079U306:
Top shareholders of NUTX - Nutex Health Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Vo Thomas T. |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
1,862,720
mixed-class rows
|
$195,014,387 | — | 09 Mar 2026 | |
| Topline Capital Management, LLC |
13F
13D/G
|
Company |
9.9%
from 13D/G
|
675,494
|
$111,199,822 | — | 31 Dec 2025 | |
| Micro Hospital Holding LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
267,728,389
|
$60,506,616 | — | 01 Apr 2022 | |
| Pertento Partners LLP |
13F
13D/G
|
Company |
5.2%
from 13D/G
|
324,422
|
$53,406,350 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
4%
|
281,553
|
$46,349,254 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.7%
|
258,743
|
$42,594,273 | — | 31 Dec 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
1.9%
|
132,041
|
$21,736,589 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.2%
|
86,792
|
$14,287,699 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
83,211
|
$13,700,407 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.1%
|
74,326
|
$12,235,546 | — | 31 Dec 2025 | |
| Matthew Stephen Young |
3/4/5
|
Director |
—
class O/S missing
|
42,134,210
|
$9,522,331 | — | 01 Apr 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.83%
|
57,640
|
$9,488,696 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.79%
|
55,025
|
$9,058,215 | — | 31 Dec 2025 | |
| Michael L. Chang |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
87,977
mixed-class rows
|
$9,009,513 | — | 09 Mar 2026 | |
| ONE PLUS ONE WEALTH MANAGEMENT, LLC |
13F
|
Company |
0.58%
|
40,441
|
$6,657,397 | — | 31 Dec 2025 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.48%
|
33,289
|
$5,480,035 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.41%
|
28,396
|
$4,674,549 | — | 31 Dec 2025 | |
| TRUIST FINANCIAL CORP |
13F
|
Company |
0.35%
|
24,419
|
$4,019,856 | — | 31 Dec 2025 | |
| DRIVE WEALTH MANAGEMENT, LLC |
13F
|
Company |
0.34%
|
23,364
|
$3,846,182 | — | 31 Dec 2025 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
0.33%
|
22,898
|
$3,769,469 | — | 31 Dec 2025 | |
| HUSSMAN STRATEGIC ADVISORS, INC. |
13F
|
Company |
0.3%
|
21,000
|
$3,457,020 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.28%
|
19,682
|
$3,240,032 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.28%
|
19,287
|
$3,175,026 | — | 31 Dec 2025 | |
| Kelvin Spears |
3/4/5
|
Director |
—
mixed-class rows
|
32,897
mixed-class rows
|
$3,064,932 | +$945 | 17 Mar 2026 | |
| Penserra Capital Management LLC |
13F
|
Company |
0.24%
|
16,851
|
$2,774,000 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.24%
|
16,398
|
$2,699,439 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.23%
|
16,133
|
$2,655,814 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.23%
|
16,045
|
$2,648,424 | — | 31 Dec 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.21%
|
14,753
|
$2,428,638 | — | 31 Dec 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.21%
|
14,484
|
$2,384,356 | — | 31 Dec 2025 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.2%
|
14,088
|
$2,319,167 | — | 31 Dec 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.16%
|
11,461
|
$1,886,709 | — | 31 Dec 2025 | |
| Warren Hosseinion |
3/4/5
|
President, Director |
—
mixed-class rows
|
20,230
mixed-class rows
|
$1,819,283 | +$23,706 | 19 Mar 2026 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.16%
|
10,869
|
$1,789,255 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.15%
|
10,214
|
$1,681,429 | — | 31 Dec 2025 | |
| Dominis-Embree AHA Investor, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
6,473,483
|
$1,463,007 | — | 26 Feb 2021 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.13%
|
8,706
|
$1,433,313 | — | 31 Dec 2025 | |
| Cetera Investment Advisers |
13F
|
Company |
0.12%
|
8,602
|
$1,416,062 | — | 31 Dec 2025 | |
| Jon Christian Bates |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
13,832
mixed-class rows
|
$1,340,823 | +$102,532 | 09 Mar 2026 | |
| Nuveen, LLC |
13F
|
Company |
0.12%
|
8,068
|
$1,328,154 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.12%
|
8,063
|
$1,327,331 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.11%
|
7,895
|
$1,299,675 | — | 31 Dec 2025 | |
| Dr. Danniel Stites |
3/4/5
|
Director |
—
class O/S missing
|
5,355,375
|
$1,210,315 | — | 01 Apr 2023 | |
| Joshua DeTillio |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
16,681
mixed-class rows
|
$1,202,653 | — | 01 Mar 2025 | |
| SummerHaven Investment Management, LLC |
13F
|
Company |
0.1%
|
7,240
|
$1,191,849 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.1%
|
7,031
|
$1,157,443 | — | 31 Dec 2025 | |
| Swiss National Bank |
13F
|
Company |
0.1%
|
7,000
|
$1,152,340 | — | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.1%
|
6,655
|
$1,095,520 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
0.09%
|
6,453
|
$1,062,293 | — | 31 Dec 2025 | |
| PFG Advisors |
13F
|
Company |
0.09%
|
6,072
|
$999,573 | — | 31 Dec 2025 |
Institutional Holders of Nutex Health Inc. - Common Stock, $0.001 par value (NUTX) as of Q1 2026
As of 31 Mar 2026,
Nutex Health Inc. - Common Stock, $0.001 par value (NUTX) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
24 shares.
The largest 1 holders included
GAMMA Investing LLC.
This page lists
1
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
115
Q1 2026 holders
1
Holder diff
-114
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.